Latest Europe News

Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.

Energy Transition Minerals (ETM) has appointed Ballard Partners as strategic advisors in the US, reinforcing its plan to list on the Nasdaq Stock Exchange and deepen its engagement with American stakeholders.

Sprintex Limited has raised A$3.625 million through option exercises and a share placement, strengthening its balance sheet and accelerating growth following a landmark €15.6 million contract with Mest Water.

Marquee Resources has reported strong initial assay results from its Phase 2 drilling at the Mt Clement Antimony Project, confirming consistent high-grade mineralisation and identifying a new Dugite Zone. These results pave the way for an updated resource estimate and further development.

Altech Batteries has won conditional approval for a €46.11 million German government grant to support its innovative CERENERGY Sodium-Chloride Solid-State battery project, advancing plans for a 120 MWh manufacturing facility in Saxony.

EcoGraf Limited has strengthened its cash position with a $1.7 million Australian R&D tax incentive and is pursuing €4 million in European grants to advance its graphite business across Tanzania and Europe.

Kuniko Limited reports promising high-grade gold and silver rock chip results at its Geenobby Prospect, confirming a structurally controlled mineralised system and setting the stage for imminent drilling in early 2026.

Memphasys Limited has completed a $579K shortfall placement, boosting total funds raised to over $1.12 million to support the commercial rollout of its Felix™ System following recent regulatory approvals.

Sprintex Limited has landed its largest-ever €15.6 million order for ZLD-UP® manure processing systems, marking a pivotal shift from evaluation to commercial deployment across Europe. This multi-year contract sets the stage for substantial revenue growth and a path to profitability in FY26.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

AnteoTech secures a significant order from the Serum Institute of India and expands its Life Sciences pipeline with new product developments and global partnerships, positioning for accelerated growth in 2026.

Clarity Pharmaceuticals’ novel diagnostic agent Cu-SAR-bisPSMA has been selected for oral presentation at the prestigious European Association of Urology Congress 2026, following promising Phase II trial results demonstrating superior detection of prostate cancer recurrence.